New Device Targets Nerve Signals to Treat Cancer-Related Wasting, Moving to First Human Trial (IMAGE)

Terasaki Institute for Biomedical Innovation

New Device Targets Nerve Signals to Treat Cancer-Related Wasting, Moving to First Human Trial

Caption

Dr. Aliesha O’Raw, Terasaki Fellow and Co-Founder of OnVagus.

Credit

Terasaki Institute for Biomedical Innovation

Usage Restrictions

For editorial use only with appropriate credit to the Terasaki Institute for Biomedical Innovation.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.